$67.51
1.291.95%
At close: Sep 9, 5:00 PM EST
$67.30
1.081.63%
Pre-Market: 4:44 AM EST
Travere Therapeutics Inc Stock News
TVTXNASDAQ
Latest Travere Therapeutics Stock News | NASDAQ:TVTX | Benzinga
Get the latest news on Travere Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Travere Therapeutics performance
Categories: All
Monday, August 10, 2026
Thursday, August 06, 2026
Wednesday, August 05, 2026
- TD Cowen Maintains Buy on Travere Therapeutic...PRO
- Citigroup Maintains Buy on Travere Therapeuti...PRO
- Evercore ISI Group Maintains Outperform on Tr...PRO
- Wynn Resorts Posts Upbeat Q2 Earnings, Joins Bloomin' Brands, Shopify, Owens Corning And Other Big Stocks Moving Higher On Wednesday
- Guggenheim Maintains Buy on Travere Therapeut...PRO
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Travere Therapeutics shares are trading highe...PRO
- Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On
Tuesday, August 04, 2026
Thursday, July 30, 2026
Thursday, June 25, 2026
Monday, June 22, 2026
Thursday, June 18, 2026
Monday, June 15, 2026
Friday, June 12, 2026
Thursday, June 04, 2026
Wednesday, June 03, 2026
Tuesday, June 02, 2026
Wednesday, May 27, 2026
Thursday, May 07, 2026
Wednesday, May 06, 2026
Tuesday, May 05, 2026
- Travere Therapeutics Plans To Offer $400M Sen...PRO
- Travere Therapeutics Analysts Increase Their Forecasts Following Q1 Earnings
- TD Cowen Maintains Buy on Travere Therapeutic...PRO
- Citigroup Maintains Buy on Travere Therapeuti...PRO
- Wedbush Maintains Outperform on Travere Thera...PRO
- HC Wainwright & Co. Maintains Buy on Travere ...PRO
Monday, May 04, 2026
Friday, April 24, 2026
Thursday, April 16, 2026
Tuesday, April 14, 2026
- Citigroup Maintains Buy on Travere Therapeuti...PRO
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Crude Oil Falls Sharply; Wells Fargo Earnings Miss Views
- Canaccord Genuity Maintains Buy on Travere Th...PRO
- Avanos Medical, Travere Therapeutics, Globalstar And Other Big Stocks Moving Higher On Tuesday
- FDA Approval For Travere's Drug Expands Reach To Broader Rare Kidney Disease Patients
- Wedbush Maintains Outperform on Travere Thera...PRO
- Guggenheim Maintains Buy on Travere Therapeut...PRO
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Travere Therapeutics share are trading higher...PRO
